4.4 Article

Active liver X receptor signaling in phagocytes in multiple sclerosis lesions

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 24, 期 3, 页码 279-289

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458517696595

关键词

Demyelinating diseases; multiple sclerosis; myelin sheath; phagocytes; liver X receptor; 27-hydroxycholesterol

资金

  1. Agentschap voor Innovatie van Wetenschap en Technologie (IWT) [131086]
  2. Fonds voor Wetenschappelijk Onderzoek (FWO) [1506916N, 1512314N, 1264114N]

向作者/读者索取更多资源

Objective: We sought to determine the liver X receptor (LXR) ligands present in human macrophages after myelin phagocytosis and whether LXRs are activated in multiple sclerosis (MS) lesions. Methods: We used real-time quantitative polymerase chain reaction (PCR) and immunohistochemistry to determine expression of LXRs and their response genes in human phagocytes after myelin phagocytosis and in active MS lesions. We used gas chromatographic/mass spectrometric analysis to determine LXRactivating oxysterols and cholesterol precursors present and formed in myelin and myelin-incubated cells, respectively. Results: Myelin induced LXR response genes ABCA1 and ABCG1 in human monocyte-derived macrophages. In active MS lesions, we found that both gene expression and protein levels of ABCA1 and apolipoprotein E (APOE) are upregulated in foamy phagocytes. Moreover, we found that the LXR ligand 27-hydroxycholesterol (27OHC) is significantly increased in human monocyte-derived macrophages after myelin uptake. Conclusion: LXR response genes are upregulated in phagocytes present in active MS lesions, indicating that LXRs are activated in actively demyelinating phagocytes. In addition, we have shown that myelin contains LXR ligands and that 27OHC is generated in human monocyte-derived macrophages after myelin processing. This suggests that LXRs in phagocytes in active MS lesions are activated at least partially by (oxy) sterols present in myelin and the generation thereof during myelin processing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Switching positions: Assessing the dynamics of conjugational heterogeneity in antibody-drug conjugates using CE-SDS

Eline B. A. van den Berg, Jaap C. W. Hendriks, Everdine W. Elsinga, Mark Eggink, Eef H. C. Dirksen

Summary: Antibody-drug conjugates (ADCs) are a promising class of oncology therapeutics that can deliver cytotoxic drugs to specific locations. This study investigated the impact of disulfide bond reduction time on drug load and isomers of ADCs, revealing a dynamic relationship between them.

ELECTROPHORESIS (2023)

Article Biochemistry & Molecular Biology

Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases

Na Zhan, Boyang Wang, Nikita Martens, Yankai Liu, Shangge Zhao, Gardi Voortman, Jeroen Van Rooij, Frank Leijten, Tim Vanmierlo, Folkert Kuipers, Johan W. Jonker, Vincent W. Bloks, Dieter Luetjohann, Marcella Palumbo, Francesca Zimetti, Maria Pia Adorni, Hongbing Liu, Monique T. Mulder

Summary: The study identified five novel LXR-activating 24-oxidized sterols with potential therapeutic applications in neurodegenerative and cardiovascular diseases. These compounds demonstrated high potency for LXR alpha/beta activation and induced the expression of LXR-target genes involved in cellular cholesterol turnover. They also enhanced cholesterol efflux and upregulated the production of endogenous LXR agonists. Overall, these findings suggest the potential of developing compounds targeting LXR for the treatment of lipid-related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages

Suzanne A. E. van Wouw, Marlene van den Berg, Maroua El Ouraoui, Amber Meurs, Jenina Kingma, Roelof Ottenhoff, Melanie Loix, Marten A. Hoeksema, Koen Prange, Gerard Pasterkamp, Jerome J. A. Hendriks, Jeroen F. J. Bogie, Jan B. van Klinken, Frederic M. Vaz, Aldo Jongejan, Menno P. J. de Winther, Noam Zelcer

Summary: LXR transcription factors play an important role in regulating the composition of lipid species in cellular membranes, particularly lysoplasmalogens. This study identified TMEM86a as a sterol-regulated lysoplasmalogenase in macrophages, which contributes to sterol-dependent membrane remodeling. TMEM86a has been found to have lysoplasmalogenase activity and its overexpression reduces lysoplasmalogen abundance and membrane fluidity in macrophages.

JOURNAL OF LIPID RESEARCH (2023)

Article Multidisciplinary Sciences

Microglia regulate central nervous system myelin growth and integrity

Niamh B. B. McNamara, David A. D. Munro, Nadine Bestard-Cuche, Akiko Uyeda, Jeroen F. J. Bogie, Alana Hoffmann, Rebecca K. K. Holloway, Irene Molina-Gonzalez, Katharine E. E. Askew, Stephen Mitchell, William Mungall, Michael Dodds, Carsten Dittmayer, Jonathan Moss, Jamie Rose, Stefan Szymkowiak, Lukas Amann, Barry W. W. McColl, Marco Prinz, Tara L. L. Spires-Jones, Werner Stenzel, Karen Horsburgh, Jerome J. A. Hendriks, Clare Pridans, Rieko Muramatsu, Anna Williams, Josef Priller, Veronique E. E. Miron

Summary: This study reveals the crucial role of resident microglia in maintaining myelin health in the central nervous system. Microglia are involved in regulating myelin growth, preserving myelin integrity, and influencing cognitive function. Disruption of the TGF beta 1-TGF beta R1 axis is implicated in the mechanism underlying the loss of myelin health. The findings suggest that targeting microglia could be a potential therapeutic approach for conditions with dysregulated myelin growth and integrity.

NATURE (2023)

Editorial Material Cell Biology

A perspective on causality assessment in epigenetic research on neurodegenerative disorders

Philippos Koulousakis, Assia Tiane, Niels Hellings, Jos Prickaerts, Daniel van den Hove, Tim Vanmierlo

NEURAL REGENERATION RESEARCH (2023)

Article Immunology

Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis

Melissa Schepers, Dean Paes, Assia Tiane, Ben Rombaut, Elisabeth Piccart, Lieve van Veggel, Pascal Gervois, Esther Wolfs, Ivo Lambrichts, Chiara Brullo, Olga Bruno, Ernesto Fedele, Roberta Ricciarelli, Charles Ffrench-Constant, Marie E. Bechler, Pauline van Schaik, Wia Baron, Evy Lefevere, Kobi Wasner, Anne Grunewald, Catherine Verfaillie, Paulien Baeten, Bieke Broux, Paul Wieringa, Niels Hellings, Jos Prickaerts, Tim Vanmierlo

Summary: Multiple sclerosis (MS) is a chronic autoimmune disease characterized by central nervous system inflammation and demyelination. Current therapies are insufficient in halting or reversing disease progression. This study shows that selective inhibition of phosphodiesterase 4 (PDE4) promotes myelin repair and reduces inflammation. Inhibition of PDE4D enhances (re)myelination, while inhibition of PDE4B exerts anti-inflammatory effects. These findings suggest that gene specific PDE4 inhibitors could be potential therapeutic agents for MS.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Pharmacology & Pharmacy

Phosphodiesterase (PDE) 4 inhibition boosts Schwann cell myelination in a 3D regeneration model

Melissa Schepers, Afonso Malheiro, Adrian Seijas Gamardo, Niels Hellings, Jos Prickaerts, Lorenzo Moroni, Tim Vanmierlo, Paul Wieringa

Summary: Phosphodiesterase 4 (PDE4) inhibitors, such as roflumilast, have been extensively studied for their anti-inflammatory and neuroregenerative properties. This study found that roflumilast can promote differentiation of Schwann cells and accelerate myelination, as demonstrated in vitro using rat cells and a 3D co-culture model. These findings contribute to the development of PDE4 inhibition-based therapies in peripheral regenerative medicine.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Biochemistry & Molecular Biology

Therapeutic administration of mouse mast cell protease 6 improves functional recovery after traumatic spinal cord injury in mice by promoting remyelination and reducing glial scar formation

Tim Vangansewinkel, Stefanie Lemmens, Assia Tiane, Nathalie Geurts, Dearbhaile Dooley, Tim Vanmierlo, Gunnar Pejler, Sven Hendrix

Summary: In this study, researchers investigated the therapeutic potential of recombinant mMCP6 in improving functional outcomes after spinal cord injury. The findings suggest that mMCP6 can enhance recovery by reducing astrogliosis and promoting (re)myelination in the injured spinal cord.

FASEB JOURNAL (2023)

Review Biochemistry & Molecular Biology

Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury

Femke Mussen, Jana Van Broeckhoven, Niels Hellings, Melissa Schepers, Tim Vanmierlo

Summary: Traumatic spinal cord injury (SCI) is characterized by severe neuroinflammation and hampered neuroregeneration. Current therapies have limited effectiveness, so new strategies targeting the initial inflammatory reactions and promoting endogenous repair are crucial. Adenosine monophosphate (cAMP) regulates these processes and inhibiting its hydrolyzing enzyme phosphodiesterase (PDE) has shown promise in modulating inflammation and promoting regeneration. This review focuses on the immunomodulatory and neuroregenerative role of cAMP-specific PDE inhibition in SCI.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell & Tissue Engineering

Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing

David Diouf, Maria Rosaria Vitale, Johanna Eva Maria Zoeller, Ana -Magdalena Pineau, Eva Klopocki, Catharina Hamann, Georg Christoph Ziegler, Tim Vanmierlo, Daniel Van den Hove, Klaus-Peter Lesch

Summary: Fibroblasts from a healthy individual were infected with a Sendai virus to produce transgene-free human induced pluripotent stem cells (iPSCs) containing the Yamanaka factors. CRISPR/Cas9 was used to create an isogenic cell line with an inactivated ST3GAL3 gene, which is associated with neurodevelopmental and psychiatric disorders. This ST3GAL3 null mutant (ST3GAL3-/-) iPSC line, with pluripotency-associated marker expression, ability to differentiate into three germ layers in vitro, and normal karyotype, provides a powerful tool to study the impact of deficient glycoprotein sialylation in neural development and plasticity.

STEM CELL RESEARCH (2023)

Article Pharmacology & Pharmacy

Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?

Ellis Nelissen, Melissa Schepers, Laura Ponsaerts, Sebastien Foulquier, Annelies Bronckaers, Tim Vanmierlo, Peter Sandner, Jos Prickaerts

Summary: Vascular cognitive impairment (VCI) is a neurodegenerative disorder characterized by a vascular component, involving decreased cerebral blood flow, white matter lesions, endothelial dysfunction, and blood-brain barrier impairments. Oxidative stress and inflammation are major underlying mechanisms. Modulation of soluble guanylate cyclase (sGC) activity can improve vascular and neural function, and has shown efficacy in cardiovascular diseases.

PHARMACOLOGICAL RESEARCH (2023)

Article Nutrition & Dietetics

Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?

Nikita Martens, Na Zhan, Gardi Voortman, Frank P. J. Leijten, Connor van Rheenen, Suzanne van Leerdam, Xicheng Geng, Michiel Huybrechts, Hongbing Liu, Johan W. W. Jonker, Folkert Kuipers, Dieter Lutjohann, Tim Vanmierlo, Monique T. T. Mulder

Summary: The nuclear liver X receptors (LXRα/β) and peroxisome proliferator-activated receptors (PPARα/γ) play a role in regulating lipid metabolism and inflammation. The activation of these receptors has neuroprotective effects and may be a potential treatment for neurodegenerative disorders like Alzheimer's Disease (AD). The brown seaweed Sargassum fusiforme contains compounds that activate these receptors and have been shown to prevent disease progression in a mouse model of AD.

NUTRIENTS (2023)

Article Cell Biology

Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720

Alessandra Roggeri, Guendalina Olivero, Cesare Usai, Tim Vanmierlo, Anna Pittaluga

Summary: This study provides evidence of the existence and distribution of inhibitory S1P1R and facilitatory S1P3R in cortical nerve endings of healthy mice. It also shows that the activity of these receptors is amplified in mice with experimental autoimmune encephalomyelitis (EAE) but can be recovered after chronic FTY720 treatment.
Meeting Abstract Medicine, Research & Experimental

Brain-penetrant sGC stimulator BAY-747 and activator runcaciguat act as cognitive enhancers via differential neuroplastic mechanisms

Ellis Nelissen, Tim Vanmierlo, Peter Sandner, Jos Prickaerts

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Meeting Abstract Medicine, Research & Experimental

sGC modulators as cognitive enhancers: neuronal and/ or vascular?

Jos Prickaerts, Ellis Nelissen, Tim Vanmierlo, Peter Sandner

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

暂无数据